SCHEMBL25769085

SCHEMBL25769085

Cc1cc(CC(=O)N2CCC[C@H]2C(=O)NCc2ccc(-c3scnc3C)cc2)on1

nearest known ligand 0.76

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ VHL P40337 20/20 0.76
▸ ELOC Q15369 6/20 0.76
▸ ELOB Q15370 6/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21697292 1.00 VHL (0.76) VHLELOCELOB
SCHEMBL20975699 0.87 VHL (0.58) VHLELOCELOB
SCHEMBL20330215 0.86 VHL (1.00) VHLELOCELOB
SCHEMBL15111829 0.86 VHL (1.00) VHLELOCELOB
SCHEMBL21696701 0.86 VHL (0.57) VHLELOCELOB
SCHEMBL21697230 0.86 VHL (0.57) VHLELOCELOB
SCHEMBL21696541 0.86 VHL (0.57) VHLELOCELOB
SCHEMBL25769171 0.86 VHL (0.58) VHLELOCELOB
SCHEMBL21697218 0.86 VHL (0.56) VHLELOCELOB
SCHEMBL21696557 0.85 VHL (0.56) VHLELOCELOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203030-A1 COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS ARVINAS OPERATIONS, INC. 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203030-A1 COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS VHL, MDM2, XIAP VHL 1/4885ELOC 203/4885ELOB 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback